US OptionsDetailed Quotes
ANGO250117C12500
- 0.10
- 0.000.00%
15min DelayTrading Dec 26 09:30 ET
0.10High0.10Low
0.10Open0.10Pre Close2 Volume23 Open Interest12.50Strike Price20.00Turnover95.89%IV40.70%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.1074Delta0.0867Gamma89.55Leverage Ratio-0.0090Theta0.0005Rho9.62Eff Leverage0.0041Vega
AngioDynamics Stock Discussion
Benzinga· 1 min ago
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife System for prostate tissue ablation.
Th...
AngioDynamics, University College London Hospital Launch International Multi-Center Study On Long Term Effects Of Treatment With NanoKnife System
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
AngioDynamics, Inc. (NASDAQ: ANGO) has launched the RECOVER-AV clinical trial to evaluate the AlphaVac F18⁸⁵ System for treating acute, intermediate-risk pulmonary embolism (PE) in the European market.
This multi-center, multi-national study follows the successful APEX-AV trial in the US, which showed significant impr...
NEWS
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
AngioDynamics (NASDAQ: ANGO) has received CE Mark approval in Europe for its AlphaVac F1885 System. This regulatory milestone allows the company to market the mechanical thrombectomy system for non-surgical removal of thrombi or emboli from the pulmonary arteries, aiding in the treatment of pulmonary embolism (PE). The system aims to improve patient outcomes in the EU, where PE has a higher...
$Valero Energy (VLO.US)$ $TORO CORP (TORO.US)$ $AngioDynamics (ANGO.US)$ $Laser Photonics (LASE.US)$ $Merck & Co (MRK.US)$ $Semtech (SMTC.US)$ $Boxed (BOXD.US)$ $Safe & Green (SGBX.US)$ $GameStop (GME.US)$ $Electronic Arts Inc (EA.US)$ $Concentrix (CNXC.US)$
In reaction to earnings/guidance:
• $Conagra Brands (CAG.US)$ +3.1%
• $Constellation Brands (STZ.US)$ +2.1%
Other news:
• $Coursera (COUR.US)$ +3.3% (names new COO)
• $International Game Technology (IGT.US)$ +2.8% (signs new 10-yr scratch ticket printing and services contract with Texas)
• $Aldeyra Therapeutics (ALDX.US)$ +2.3% (Achieves Primary Endpoint in Part 1 of Phase 3 GUARD Trial of ADX-2191)
• $Gol Intelligent Airlines (GOL.US)$ +1.5% (re...
• $AngioDynamics (ANGO.US)$ +13.5%, $Skillsoft (SKIL.US)$ +3.26%, $Sprinklr (CXM.US)$ +8.96%, $Cazoo (CZOO.US)$ +11.1%, $Apogee Enterprises (APOG.US)$ +3.3%, $Levi Strauss & Co. (LEVI.US)$ +1.7%, $Constellation Brands (STZ.US)$ + 0.8%
• $Momentus (MNTS.US)$ +36.9% (signed multiple launch agreements with Space Exploration Technologies Corp)
• $HP Inc (HPQ.US)$ +10.1% (Berkshire Hathaway's Warren Buffett disclosed the purchase of mln sh...
No comment yet